Rising Prevalence of Chronic Diseases Propels APAC Infusion Pumps Market

https://www.marketsandmarkets.....com/Market-Reports/a

The APAC infusion pumps market is dominated by Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Fresenius Kabi (Germany), Baxter International (US), and Medtronic PLC (Ireland).

The APAC infusion pumps market is expected to reach USD 5.7 billion by 2027 from an estimated USD 3.7 billion in 2022, at a CAGR of 9.1%. The rising demand for ambulatory infusion pumps in homecare settings, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, increasing adoption of enteral feeding pumps with surge in pre-term births, growing number of surgical procedures performed, and increasing number of ICU beds in countries with a high prevalence of COVID-19 are some of the key factors driving the growth of the APAC infusion pumps market. However, the presence of stringent regulations for new products, medication errors associated with infusion pumps (which have resulted in product recalls), and the increasing adoption of refurbished and rental infusion pumps are expected to restrain the growth of this market during the forecast period.